Literature DB >> 18235984

Age- and sex-related incidence of surgically treated primary hyperparathyroidism.

Barbra S Miller1, Justin Dimick, Reid Wainess, Richard E Burney.   

Abstract

BACKGROUND: Primary hyperparathyroidism (1 degrees HPT) is reported most often in women over the age of 50. Beyond that, little is known about the epidemiology of this condition, and no studies have specifically examined the age and gender distribution of patients with 1 degrees HPT.
METHODS: We analyzed patients from the Nationwide Inpatient Sample (NIS), a 20% random sample of all hospital stays from 2000-2004, and also from the University of Michigan endocrine surgery database from 1999-2005. Surgically treated 1 degrees HPT was used as a surrogate marker for 1 degrees HPT. An age- and sex-based frequency distribution was computed for each dataset.
RESULTS: A total of 7,513 females and 2,677 males who underwent surgery for 1 degrees HPT in the 5-year period 2000 through 2004 were reported in the NIS. At the University of Michigan from 1999 through 2005, 790 females and 276 males underwent parathyroidectomy for 1 degrees HPT. In both datasets, the frequency of 1 degrees HPT began to rise slowly in both sexes at age 11 and increased more rapidly among females than males beginning at age 21-25 (NIS) and 26-30 (UM). Incidence curves for both women and men in both databases were similar in shape and unipolar in configuration. Peak incidence was at age 56-60 (NIS) and 61-65 (UM) in females and age 56-60 in males (both datasets). The female:male ratio was noted to rise steadily among the NIS patients until perimenopausal age, after which it became stable for the next 20 years before decreasing again. No change in the female:male ratio over time was seen among the UM patients.
CONCLUSIONS: Primary HPT occurs more frequently in females than in males at all ages. The incidence increases steadily after age 25 in both sexes. The female:male ratio does not change during the peri- and postmenopausal years. This information should stimulate new hypotheses to explain the difference in the incidence of 1 degrees HPT between men and women.

Entities:  

Mesh:

Year:  2008        PMID: 18235984     DOI: 10.1007/s00268-007-9427-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

Review 1.  Clinical spectrum of primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Childbearing and the risk of parathyroid adenoma--a dominant cause for primary hyperparathyroidism.

Authors:  J Rastad; A Ekbom; H Hultin; J Wuu; E Lundgren; C C Hsieh; M Lambe
Journal:  J Intern Med       Date:  2001-07       Impact factor: 8.989

Review 3.  Hyperparathyroidism and pregnancy.

Authors:  K C Kort; H J Schiller; P J Numann
Journal:  Am J Surg       Date:  1999-01       Impact factor: 2.565

4.  Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement.

Authors:  C Joborn; S Ljunghall; K Larsson; E Lindh; T Naessén; L Wide; G Akerström; J Rastad
Journal:  Clin Endocrinol (Oxf)       Date:  1991-05       Impact factor: 3.478

5.  The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.

Authors:  R A Wermers; S Khosla; E J Atkinson; S F Hodgson; W M O'Fallon; L J Melton
Journal:  Ann Intern Med       Date:  1997-03-15       Impact factor: 25.391

Review 6.  Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.

Authors:  George Wells; Peter Tugwell; Beverley Shea; Gordon Guyatt; Joan Peterson; Nicole Zytaruk; Vivian Robinson; David Henry; Diane O'Connell; Ann Cranney
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

7.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 8.  Epidemiology of primary hyperparathyroidism.

Authors:  L J Melton
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

9.  Selective estrogen receptor modulators inhibit the effects of insulin-like growth factors in hyperparathyroidism.

Authors:  Chris Wong; Teresa Lai; Jeff M P Hilly; Claire E H Stewart; John R Farndon
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

10.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

View more
  19 in total

1.  Intraoperative real-time (99m)Tc-sestamibi scintigraphy with miniature gamma camera allows minimally invasive parathyroidectomy without ioPTH determination in primary hyperparathyroidism.

Authors:  Norberto Cassinello; Joaquin Ortega; Salvador Lledo
Journal:  Langenbecks Arch Surg       Date:  2009-06-27       Impact factor: 3.445

2.  Effect of gender and geographic location on the expression of primary hyperparathyroidism.

Authors:  F De Lucia; S Minisola; E Romagnoli; J Pepe; C Cipriani; A Scillitani; N Parikh; D S Rao
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

Review 3.  Primary hyperparathyroidism in pregnancy.

Authors:  Gonzalo Diaz-Soto; Agnès Linglart; Marie-Victoire Sénat; Peter Kamenicky; Philippe Chanson
Journal:  Endocrine       Date:  2013-05-14       Impact factor: 3.633

4.  Does multiple gland disease in primary hyperparathyroidism correlate with age or sex?

Authors:  Denis Wirowski; Bernhard J Lammers; Peter Pohl; Katharina Schwarz; Peter E Goretzki
Journal:  Langenbecks Arch Surg       Date:  2009-06-17       Impact factor: 3.445

5.  Primary hyperparathyroidism in adolescents: the same but different.

Authors:  Itai Pashtan; Raymon H Grogan; Sharone P Kaplan; Karen Devon; Peter Angelos; Donald Liu; Edwin L Kaplan
Journal:  Pediatr Surg Int       Date:  2012-11-25       Impact factor: 1.827

6.  Is There a Gender Difference in Clinical Presentation of Renal Hyperparathyroidism and Outcome after Parathyroidectomy?

Authors:  Claudia Bures; Tatjana Skachko; Eva M Dobrindt; Johann Pratschke; Deniz Uluk; Martina T Mogl
Journal:  Visc Med       Date:  2020-01-20

7.  MINIMALLY INVASIVE PARATHYROIDECTOMY FOR PRIMARY HYPERPARATHYROIDISM.

Authors:  M Urkan; Y S Peker; E Ozturk
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

8.  Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study.

Authors:  Julie M Paik; Gary C Curhan; Eric N Taylor
Journal:  BMJ       Date:  2012-10-17

9.  Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B.

Authors:  Marianne S Elston; Goswin Y Meyer-Rochow; Michael Dray; Michael Swarbrick; John V Conaglen
Journal:  Case Rep Endocrinol       Date:  2015-07-14

10.  Epidemiology of Primary Hyperparathyroidism and its Non-classical Manifestations in the City of Recife, Brazil.

Authors:  Cátia Eufrazino; Andreia Veras; Francisco Bandeira
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2013-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.